small lymphocytic lymphoma

Secura Bio to keep offering blood cancer drug despite negative ODAC vote, OS questions
Endpoints
Thu, 03/23/23 - 08:59 pm
Secura Bio
Copiktra
CLL
small lymphocytic lymphoma
FDA
TG Therapeutics Backpedals on BLA for Lymphoma, Leukemia Treatment
BioSpace
Mon, 04/18/22 - 10:58 am
TG Therapeutics
ublituximab-umbralisib
chronic lymphocytic leukemia
small lymphocytic lymphoma
BeiGene tees up 3-way leukemia competition against J&J-AbbVie, AstraZeneca with Brukinsa win
Fierce Pharma
Mon, 08/2/21 - 10:57 am
BeiGene
Brukinsa
CLL
small lymphocytic lymphoma
clinical trials
FDA Gives Greenlight to Janssen and AbbVie's Imbruvica for the 10th Time
BioSpace
Mon, 01/28/19 - 12:11 pm
Imbruvica
Janssen
AbbVie
Roche
Gazyva
chronic lymphocytic leukemia
small lymphocytic lymphoma
FDA
ASCO18: AbbVie blood cancer combo off to a strong start in Phase 2
Biopharma Dive
Mon, 06/4/18 - 09:37 am
AbbVie
Imbruvica
Venclexta
chronic lymphocytic leukemia
small lymphocytic lymphoma
ASCO 2018
At Verastem, Infinity’s Former Blood Cancer Drug Heads to FDA
Xconomy
Fri, 02/9/18 - 09:34 am
Verastem
Infinity Pharma
FDA
duvelisib
CLL
follicular lymphoma
small lymphocytic lymphoma
Verastem moves closer to US filing for blood cancer drug
BioPharma Dive
Wed, 11/1/17 - 06:58 pm
Verastem
duvelisib
chronic lymphocytic leukemia
small lymphocytic lymphoma
AbbVie Builds Upon Robust Body of IMBRUVICA® (ibrutinib) Data with Phase 3 Longer-Term Studies in Patients with Chronic Lymphocytic Leukemia and Small Lymphocytic Lymphoma Presented at the American Society of Clinical Oncology (ASCO) Annual Meeting
Yahoo
Mon, 06/6/16 - 11:23 am
AbbVie
Imbruvica
CLL
small lymphocytic lymphoma
ASCO 2016
FDA approves Gilead Sciences' Zydelig for 3 forms of blood cancer
Yahoo/AP
Wed, 07/23/14 - 04:33 pm
FDA
Zydelig
Gilead Sciences
chronic lymphocytic leukemia
follicular lymphoma
small lymphocytic lymphoma
This Small Company Is Winning the War Against Blood Cancer
Motley Fool
Wed, 08/21/13 - 06:59 pm
Pharmacyclics
mantle cell lymphoma
small lymphocytic lymphoma
chronic lymphocytic leukemia
ibrutinib